Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

6 Dec 2013 17:46

RNS Number : 9748U
Ark Therapeutics Group PLC
06 December 2013
 



BLOCK LISTING SIX MONTHLY RETURN

 

Date: 6 December 2013

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Unapproved Share Option Scheme

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

2,271,252

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

2,271,252

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

939,433

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

939,433

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group 2005 Long Term Incentive Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

683,200

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

683,200

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Approved Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

1,000,000

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 002 1005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDMMGZNVDGFZM
Date   Source Headline
22nd Apr 20093:34 pmRNSAGM Results
7th Apr 200911:09 amRNSAnnual Information Update
7th Apr 20097:00 amRNSResearch Update
17th Mar 20095:03 pmRNSHolding(s) in Company
13th Mar 20094:25 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSFinal Results
2nd Mar 200911:21 amRNSVoting Rights and Capital
26th Feb 20097:00 amRNSPatent Filing
17th Feb 20092:14 pmRNSHolding(s) in Company
16th Feb 20095:39 pmRNSHolding(s) in Company
16th Feb 20097:00 amRNSResearch Update
5th Feb 200910:50 amRNSDealing by Employee Benefit Trust
2nd Feb 20097:00 amRNSDirector/PDMR Shareholding
21st Jan 20094:40 pmRNSSecond Price Monitoring Extn
21st Jan 20094:37 pmRNSPrice Monitoring Extension
21st Jan 200912:12 pmRNSNotice of Results
14th Jan 20097:00 amRNSRe Agreement
9th Jan 200910:23 amRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrinam Phase III trial to commence
6th Jan 20097:00 amRNSResearch Update
31st Dec 20089:00 amRNSTotal Voting Rights
16th Dec 20083:46 pmRNSNotification of Major Interests in Shares
9th Dec 20084:40 pmRNSSecond Price Monitoring Extn
9th Dec 20084:35 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSRegulatory Approval
5th Dec 20082:28 pmRNSBlocklisting Six Monthly Return
1st Dec 20087:00 amRNSRegulatory Application
24th Nov 200811:58 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSInterim Management Statement
20th Oct 20087:00 amRNSProduct Launch
2nd Oct 20087:00 amRNSArk secures reimbursement for Neuropad
30th Sep 20085:06 pmRNSVoting Rights and Capital
17th Sep 20081:08 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
27th Aug 20087:00 amRNSResearch Update
26th Aug 20084:08 pmRNSHolding(s) in Company
1st Aug 200810:47 amRNSVoting Rights and Captial
31st Jul 20081:12 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSResearch Update
16th Jul 20087:00 amRNSResearch Update
8th Jul 200811:00 amRNSArk opens new manufacturing f
24th Jun 200811:28 amRNSHolding(s) in Company
18th Jun 20087:00 amRNSResearch Update
6th Jun 200812:10 pmRNSBlocklisting Application
3rd Jun 200810:58 amRNSBlocklisting Interim Review
3rd Jun 200810:51 amRNSBlocklisting Interim Review
2nd Jun 20087:00 amRNSRegulatory Approval
30th May 20084:52 pmRNSVoting Rights and Capital
30th May 20087:00 amRNSResearch Update
22nd May 20081:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.